
    
      MTD Expansion I(Phase II): A total of 18-32 patients with epithelial ovarian, primary
      peritoneal, fallopian tube or mixed mullerian tumours of ovarian origin, in need of relapse
      treatment will be enrolled.

      MTD Expansion II (phase II): A total of 15 patients with urothelial (transitional cell)
      carcinoma of the bladder will be enrolled.
    
  